https://www.selleckchem.com/products/gsk503.html
MicroRNAs (miRNAs) have been reported as biomarkers for various diseases, including cerebral atherosclerosis (AS). In the present study, whether serum microRNA-137 (miR-137) could be used as a biomarker for diagnosing cerebral AS and predicting cerebrovascular event was investigated. Quantitative real-time PCR was used to measure the expression of miR-137 in serum. Logistic analysis was used to evaluate the risk factors for the occurrence of cerebral AS, and receiver operating characteristic (ROC) curves were used to estimate the diagnos
Like
Comment
Share
